The use of systems biology in chemical risk assessment-Reference-Cited by-同舟云学术

The use of systems biology in chemical risk assessment

Published:2019-06 Issue: Volume:15 Page:48-54
ISSN:2468-2020
Container-title:Current Opinion in Toxicology
language:en
Short-container-title:Current Opinion in Toxicology

Author:

Aguayo-Orozco Alejandro,Taboureau Olivier,Brunak Søren

Funder

European Union's Horizon 2020

Nolvo Nordisk Foundation

Publisher

Elsevier BV

Subject

Toxicology

Reference55 articles.

1. Systems toxicology: from basic research to risk assessment;Sturla;Chem Res Toxicol,2014

2. Guidance document of developing and assessing adverse outcome pathways;Organisation for Economic Co-operation and Development (OECD);Series Test Assess,2013

3. Methotrexate pharmacokinetics;Bischoff;J Pharm Sci,1971

4. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride;Andersen;Toxicol Appl Pharmacol,1987

5. History of pharmacokinetics;Wagner;Pharmacol Ther,1981

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. The Potential of Systems Biology to Understand the Tenets of Host-pathogen Interaction, Toxicology, and Aging;Systems Biology Approaches: Prevention, Diagnosis, and Understanding Mechanisms of Complex Diseases;2024

3. Systems Biology in Immunotoxicology;Reference Module in Biomedical Sciences;2024

4. Risk Assessment;Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology;2023

5. Application of radiation omics in the development of adverse outcome pathway networks: an example of radiation-induced cardiovascular disease;International Journal of Radiation Biology;2022-08-24